NORCROSS, Ga., June 2, 2014 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that the Notice of Intent to Revoke (“NOIR”) has been lifted.
Help employers find you! Check out all the jobs and post your resume.
